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Purpose
The purpose of this study was to investigate the dosimetric benefits and treatment efficiency
of carotid-sparing TomoHelical 3-dimensional conformal radiotherapy (TH-3DCRT) for early
glottic cancer.
Materials and Methods
Ten early-stage (T1N0M0) glottic squamous cell carcinoma patients were simulated, based
on computed tomography scans. Two-field 3DCRT (2F-3DCRT), 3-field intensity-modulated
radiation therapy (3F-IMRT), TomoHelical-IMRT (TH-IMRT), and TH-3DCRT plans were 
generated with a 67.5-Gy total prescription dose to the planning target volume (PTV) for
each patient. In order to evaluate the plan quality, dosimetric characteristics were compared
in terms of conformity index (CI) and homogeneity index (HI) for PTV, dose to the carotid 
arteries, and maximum dose to the spinal cord. Treatment planning and delivery times were
compared to evaluate treatment efficiency.
Results
The median CI was substantially better for the 3F-IMRT (0.65), TH-IMRT (0.64), and 
TH-3DCRT (0.63) plans, compared to the 2F-3DCRT plan (0.32). PTV HI was slightly better
for TH-3DCRT and TH-IMRT (1.05) compared to 2F-3DCRT (1.06) and 3F-IMRT (1.09). 
TH-3DCRT, 3F-IMRT, and TH-IMRT showed an excellent carotid sparing capability compared
to 2F-3DCRT (p < 0.05). For all plans, the maximum dose to the spinal cord was < 45 Gy.
The median treatment planning times for 2F-3DCRT (5.85 minutes) and TH-3DCRT (7.10 
minutes) were much lower than those for 3F-IMRT (45.48 minutes) and TH-IMRT (35.30
minutes). The delivery times for 2F-3DCRT (2.06 minutes) and 3F-IMRT (2.48 minutes) were
slightly lower than those for TH-IMRT (2.90 minutes) and TH-3DCRT (2.86 minutes).
Conclusion
TH-3DCRT showed excellent carotid-sparing capability, while offering high efficiency and
maintaining good PTV coverage.
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Introduction
Early glottic cancer (EGC) is a highly curable malignancy.
Radiation therapy (RT) has been established as the primary
treatment option for EGC at most institutions due to its long-
term benefits, such as voice preservation [1,2]. Traditional RT
for EGC uses lateral opposed fields (LOF) with low-energy
photons. However, the carotid arteries (CAs) receive the full
prescription dose with LOF because they are located to the
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left and right of the target volume (TV). As a result, increased
incidences of stroke and other cerebrovascular events have
been reported in patients who have survived over 10 years
since undergoing the treatment for EGC [3-5]. In particular,
the risk of ischemic stroke increases 10-fold in patients 
undergoing traditional RT for EGC if younger than 60 years
of age [5].  
For these reasons, various treatment techniques have been
introduced to decrease the dose administered to CA during
RT for EGC [6-9]. Intensity-modulated radiation therapy
(IMRT) can maintain good coverage while significantly 
reducing the dose administered to the CA, as compared with
traditional LOF and 3-dimensional conformal RT (3DCRT)
[6-8]. Further, Chatterjee et al. [9] have reported that helical
tomotherapy-based IMRT offers significant improvements to
CA sparing. Inverse planning–based IMRT is highly effective
in reducing the dose to adjacent organ at risks (OAR) and
improves target dose conformity by controlling the beam 
intensity. However, as compared with 3DCRT, IMRT 
involves complicated treatment plans that are closely related
to poor treatment efficiency, as well as to long planning and
treatment times. The complicated plans also require addi-
tional pretreatment quality assurance in busy clinics [10].
Furthermore, as compared with 3DCRT, these more compli-
cated plans are associated with higher risks of error. In 
particular, IMRT is associated with higher risk of inaccurate
dose delivery to moving targets, which results from the 
interplay between multi-leaf-collimator (MLC) and organ
motions [11]. Because the TV is relatively small in cases of
EGC, it is more likely to be influenced by movement during
IMRT, and therefore requires careful consideration [12,13]. 
Tomotherapy options can be classified as either IMRT or
3DCRT, as performed using either a helical mode or a direct
mode (fixed beams), depending on the dose planning and
beam delivery technique. TomoHelical 3DCRT (TH-3DCRT)
is a form of helical conformal arc therapy. It has the advan-
tage of offering plan and beam delivery times that are 
generally shorter than those associated with IMRT. 
TH-3DCRT presents these time-advantages because it does
not include an intensity-modulation process that relies upon
inverse planning. Thus, TH-3DCRT can be an effective RT
modality for EGC and other targets that have simple shapes
and do not require complex beam-intensity modulation 
(because the internal beam path length is short).
Recently, researchers have used dosimetric comparison
studies to identify the techniques that minimize the CA dose
in RT for EGC. However, prior studies have not included
clear comparisons of the dosimetric characteristics of helical
tomotherapy (TH-IMRT) and linear-accelerator-based IMRT.
Further, prior comparison studies have not investigated 
TH-3DCRT for EGC. In the present study, we compared
3DCRT, IMRT, TH-IMRT, and TH-3DCRT in terms of their
dosimetric characteristics and treatment time efficiencies for
EGC. By performing this comparison, we aimed to evaluate
the performance of various treatment techniques in clinical
application.
Materials and Methods
1. Patient selection and definition of the TV
Between February 2013 and December 2014, a total of 21
patients with early glottis carcinoma (cT1-2N0M0) were
treated with definitive RT. We selected 10 of these patients
for this study, each of whom had T1N0 glottic squamous cell
carcinoma and underwent curative RT with daily image-
guidance. All patients underwent computed tomography
(CT) (2.5-mm slice thickness; LightSpeed, GE Healthcare,
Milwaukee, WI) after being immobilized in supine position,
using thermoplastic masks. Each patient’s CT image dataset
was transferred to the treatment planning system (TPS) (Pin-
nacle3 ver. 9.2, Philips Medical System, Madison, WI), and
the clinical target volume (CTV), planning target volume
(PTV), spinal cord, and both CAs were delineated. The CTV
was delineated based on the traditional 5!5 cm2 field size.
The beam isocenter was placed at the level of the true vocal
cords [6]. The CTV was contoured as follows: superiorly, at
the thyroid notch or at the most cranial extent of arytenoid
cartilage; inferiorly, at 1-1.5 cm below the level of the true
vocal cord; posteriorly, the CTV included arytenoid cartilage
and posterior commissure; and anterolaterally, the CTV was
drawn along the inner portion of the thyroid cartilage and
encompassed the anterior commissure. To create the PTV,
the CTV was expanded by 3 mm in the lateral and anterior
directions and by 1 mm in the posterior direction. A lesser
expansion was used in the posterior direction because we
sought to reduce the irradiated dose to the posterior pharyn-
geal wall. With regard to clinical structures, the CAs and the
spinal cord were delineated. Such OAR volumes were delin-
eated up to 2-cm superiorly and inferiorly beyond PTV. 
2. Treatment planning 
For each patient, four sets of treatment plans were created
to analyze the dosimetric characteristics and treatment time 
efficiency: (1) 2-field 3DCRT (2F-3DCRT), (2) 3-field IMRT
(3F-IMRT), (3) TH-IMRT, and (4) TH-3DCRT. 2F-3DCRT and
3F-IMRT were planned using a Pinnacle TPS with a Clinac
6EX (Varian, Palo Alto, CA). TH-IMRT and TH-3DCRT 
were planned using a TomoTherapy TPS with a TomoHD 
(TomoTherapy, Accuray, Sunnyvale, CA). All plans involved
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6-MV X-rays. We employed 2-mm (Pinnacle) and 1.95-mm
(TomoTherapy) dose calculation grid sizes. The prescription
dose was 67.5 Gy in 30 fractions (2.25 Gy per fraction) to the
PTV. All plans were normalized such that 95% of the PTV 
received 100% of the prescription dose. 
Traditional LOF was not included in this study because it
generally results in a high CA dose. Instead, two wedged 
anterior-oblique fields (2F-3DCRT, gantry angles 70° and
290°) were used to provide more effective means of reducing
the CA dose. For the 3F-IMRT, an anterior field was added
to the same right and left anterior oblique fields that were
employed in 2F-3DCRT. The direct machine parameter opti-
mization module, supplied by the TPS manufacturer, was
used for dose optimization, which was performed via inverse
planning. To provide the PTV dose constraint for inverse
planning, PTV was set to meet the prescription dose (Table
1) [6]. The volumes of the CA receiving 35 Gy and 10 Gy were
constrained to be below 20% and 50%, respectively. Finally,
the spinal cord dose was constrained to be below 45 Gy. For
each plan, we used the same number of iterations (250) 
during the dose optimization process. During inverse plan-
ning, the priority was given to PTV. When the PTV dose
reached the constraint early, optimization was continued to
reduce the OAR dose until the iteration limit, while main-
taining the PTV dose. 
For TH-IMRT, we used a field width of 2.5 cm, a modula-
tion factor of 2.0, and a pitch of 0.287 (to avoid the thread 
effect). TH-IMRT inverse planning involved the same num-
ber of iterations, and the same dose constraints that were
specified above for 3F-IMRT. To spare the CA, a directional
blocking was applied to the right and left CA, thus disabling
the primary beam if the blocked structure was proximal to
the target, but not if the beamlets entered the target first. 
TH-3DCRT was performed under the same conditions as
TH-IMRT, with the exception of intensity modulation.
3. Comparison of dosimetric characteristics and treatment
efficiency
To quantitatively evaluate the plan quality under identical
conditions, all calculated plans were transferred to the same
dose evaluation software (MIM Maestro, MIM Software Inc.,
Cleveland, OH), using the DICOMRT protocol. Dose-volume
histograms (DVHs) for PTV, CA, and spinal cord were cal-
culated for all plans, and the mean DVH was evaluated
based on the results. To evaluate the PTV dose coverage, the
conformity index (CI) and homogeneity index (HI) were 
calculated for PTV under each plan [14,15]. CI is defined as
follows:
, where PTVPIV is the PTV encompassed within PIV, which is
the volume covered by the prescription isodose surface. HI
is an indication of dose uniformity within PTV; a value of 
1 indicates a uniform PTV dose distribution, an ideal value.
HI is defined as follows:
, where D2 and D98 are the minimum doses received by 2%
and 98% of PTV, respectively.
We calculated V35, V50, V63 (VD: the percentage of the organ
volume receiving D Gy or more), and maximum dose (Dmax)
for both CAs. The spinal cord dose was compared with the
maximum dose. 
To evaluate the treatment time efficacies of the four treat-
ment methods, the planning and treatment times of each
plan were compared. To provide an objective measurement,
planning time only included the beam generation, optimiza-
tion, and dose-calculation times, as performed by a senior
dosimetrist with 10 years of experience in IMRT planning.
The target and OAR-contouring times were excluded. Four
sets of plan for each patient were generated continuously and
without any interruption in the same manner. The treatment
time only included practical treatment time, excluding the
patient setup time. In other words, after patient setup verifi-
cation was completed, the time between the first beam-on
and the last beam-off was measured. The Wilcoxon signed-
rank test and the Bonferroni correction were used to compare
the following differences: 2F-3DCRT versus TH-3DCRT, 
3F-IMRT versus TH-3DCRT, and TH-IMRT versus TH-
3DCRT. Our statistical analysis was performed using SAS
ver. 9.4 (SAS Institute Inc., Cary, NC). A 2-tailed p-value 
< 0.05 was considered statistically significant.
CI= PTVPIV
2
PTV×PIV
HI= D2D98
Table 1. Dose constraints for inverse planning
Structure Constraint
PTV D95 " 67.5 Gy
Spinal cord Dmax # 45 Gy
Carotid artery V30 # 20%
V10 # 50%
PTV, planning target volume; Dx, dose received by x% of
the volume; Dmax, maximum dose; VD, the percentage of
the organ volume that received D Gy or more.
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Results
1. Plan comparison
The 4 types of plans were associated with significantly 
different dose distributions for the same patients with EGC
(Fig. 1). As viewed from the axial plane at the target center,
unnecessary irradiation was observed on the left and right
sides of the target under the 2F-3DCRT plan, as a conse-
quence of the broad distribution of the regions receiving the
prescribed dose, which was wider than observed under the
other 3 plans. This resulted in a lower CI (median, 0.32; 
interquartile rage, 0.3 to 0.35) than was observed for the other
plans (Table 2). Conformity improved in the following order:
3F-IMRT, TH-IMRT, and TH-3DCRT (Fig. 1). However, we
found no statistically significant differences between the CIs
associated with the plans (p > 0.05) (Table 2). The TH-3DCRT
and TH-IMRT plans did not result in significantly different
HIs. Further, the TH-3DCRT and 2F-3DCRT plans did not 
result in significantly different HIs. However, the 3F-IMRT
plan resulted in a slightly higher HI than did the TH-3DCRT
plan (p < 0.05).
The CA was included within the volume that received the
prescription dose under the 2F-3DCRT plan. Accordingly,
Fig. 1.  An axial view of isodose distributions at the target center for each of the four treatment plans and a single represen-
tative patient. (A) Two-field 3-dimensional conformal radiotherapy (2F-3DCRT). (B) Three-field intensity-modulated radia-
tion therapy. (C) TomoHelical IMRT. (D) TomoHelical 3DCRT. Under 2F-3DCRT, the high-dose region that received the
prescription dose was widely distributed over the carotid artery. Under the other three plans, the high-dose region did not
include the carotid artery.
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Fig. 2.  This figure shows the mean dose-volume histog-
ram (10 patients) for the carotid artery, including results for
each of the four treatment plans that were investigated. In
our treatment-planning simulations, the normalized vol-
ume of the carotid artery that received in excess of 30 Gy
was the lowest using TomoHelical intensity-modulated 
radiation therapy (TH-IMRT), the second-lowest using 
TomoHelical 3-dimensional conformal radiotherapy (TH-
3DCRT), the third-lowest using 3-field IMRT (3F-IMRT),
and the highest using 2-field 3DCRT (2F-3DCRT).
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the 2F-3DCRT plan was associated with a higher CA dose
than the other 3 plans, under which the high-dose region did
not include CA (Fig. 1). These results are reflected by the
mean DVH for each plan (Fig. 2). V35, V50, and V63 were also
observed to be very high under the 2F-3DCRT plan, as com-
pared with the other plans (p < 0.05) (Table 2). Furthermore,
there were no results indicating that the CA exceeded V50 or
V63 in the 3F-IMRT, TH-IMRT, and TH-3DCRT plans. There
were no significant differences in V35 between TH-3DCRT
and TH-IMRT (p > 0.05). However, 3F-IMRT resulted in a
slightly higher V35 than TH-3DCRT (p < 0.05). Under the 
2F-3DCRT plan, the median of the maximum CA doses
(69.82 Gy; range, 69.23 to 70.41) exceeded the prescription
dose. Further, 3F-IMRT resulted in a significant increase in
this median of maximums compared to TH-IMRT and TH-
3DCRT (p < 0.05). Under each of the plans, the maximum
dose to the spinal cord was below 45 Gy.
2. Efficiency
Both 3F-IMRT and TH-IMRT required inverse planning,
and their median planning times were 45.5 and 35.3 minutes,
respectively. In contrast, 2F-3DCRT and TH-3DCRT did not
require inverse planning, and their median planning times
were only 5.8 and 7.1 minutes, respectively (Table 2). The
TH-3DCRT median beam delivery time did not differ signif-
icantly from the TH-IMRT median beam delivery time, but
was slightly longer than the 2F-3DCRT and 3F-IMRT median
beam delivery times (p < 0.05). However, each of the differ-
ences was less than 1 minute.
Table 2. Comparisons of dosimetric characteristics and delivery efficiencies for different treatment techniques
p-value
Parameter 2F-3DCRT 3F-IMRT TH-IMRT TH-3DCRT 2F-3DCRT vs. 3F-IMRT vs. TH-IMRT vs. 
TH-3DCRT TH-3DCRT TH-3DCRT
PTV
CI 0.32 0.65 0.64 0.63 0.01a) 0.83 0.39
(0.3-0.35) (0.62-0.67) (0.60-0.68) (0.60-0.67)
HI 1.06 1.09 1.05 1.05 0.39 0.01a) > 0.99
(1.05-1.07) (1.08-1.10) (1.05-1.06) (1.048-1.063)
Carotid artery
V35 (%) 33.88 0.30 0.00 0.00 0.01a) 0.01a) > 0.99
(20.44-41.36) (0.05-0.30) (0.00-0.00) (0.00-0.00)
V50 (%) 18.48 0.00 0.00 0.00 0.01a) > 0.99 > 0.99
(9.01-25.15) (0.00-0.00) (0.00-0.00) (0.00-0.00)
V63 (%) 7.97 0.00 0.00 0.00 0.01a) > 0.99 > 0.99
(3.97-13.17) (0.00-0.00) (0.00-0.00) (0.00-0.00)
Dmax (%) 69.82 38.71 29.23 30.31 0.01a) 0.01a) 0.09
(69.23-70.41) (35.55-43.52) (26.37-32.28) (27.53-34.15)
Spinal cord
Dmax (%) 2.58 28.05 24.86 26.76 0.01a) 0.97 0.01a)
(2.38-3.55) (27.03-28.77) (23.48-27.52) (24.76-29.42)
Planning time 5.85 45.48 35.30 7.10 0.01a) 0.01a) 0.01a)
(min) (5.50-6.25) (40.65-48.28) (32.91-40.78) (6.35-8.40)
Delivery time 2.06 2.48 2.90 2.86 0.01a) 0.01a) > 0.99
(min) (1.99-2.11) (2.45-2.51) (2.81-2.97) (2.73-3.00)
Pretreatment ! ! ! ! - - -dosimetric QA
Values are presented as median (interquartile range). 2F-3DCRT, 2-field 3-dimensional conformal radiotherapy; 3F-IMRT, 
3-field intensity-modulated radiation therapy; TH-IMRT, TomoHelical IMRT; TH-3DCRT, TomoHelical 3DCRT; PTV, planning
target volume; CI, conformity index; HI, homogeneity index; VD, the percentage of the organ volume that received D Gy or
more; Dmax, maximum dose; QA, quality assurance. a)Statistically significant. 
Discussion
RT with LOF has played an important role in the treatment
of EGC for a long time. However, studies have reported that
the excessive radiation dose received by CA can increase the
risk of stroke due to the development of stenosis and thick-
ening of the vessel wall [3,4]. Accordingly, there is growing
interest in using the latest RT techniques to reduce the irra-
diation of the CA. There are several advantages to the 
complicated new treatment techniques; however, these tech-
niques also have disadvantages, such as increased workloads
and high probability of error. Further study is necessary to
clarify the balance of these advantages and disadvantages.
In particular, performing RT for EGC with a very low dose
to CA results in both the deterioration of target coverage and
rapid increase in workload. The exact dose-response relation-
ship for CA irradiation remains unclear. However, studies
have reported statistically significant thickening of the vessel
wall for doses of more than 35-50 Gy [16]. Hence, we did not
consider CA doses of less than 35 Gy, while generating 4 
different plans for this study.
Our study considered 2F-3DCRT, which provides a more
efficient method of lowering the CA dose, as compared with
the traditional LOF technique. When indirectly comparing
our results with previous studies, we found that 2F-3DCRT
provides better target dose conformity and CA sparing than
traditional LOF [17]. In addition, 3-field (right anterior
oblique, left anterior oblique, and an anterior field) 3DCRT
shows a slightly better CA sparing than 2F-3DCRT [6]. In this
study, however, 3DCRT resulted in a lower CI and a higher
CA dose than the other three plans. For this reason, various
forms of IMRT techniques for EGC RT have recently been 
introduced, such as volumetric-modulated arc therapy
(VMAT). VMAT was not included in this study, but has 
recently been the subject of considerable attention [18]. When
comparing previous investigations of various VMAT tech-
niques with the results of this study, only full-arc VMAT 
offered a V35 that was similar to our findings for 3F-IMRT,
TH-IMRT, and TH-3DCRT (a V35 that was close to 0). 
As compared with 3DCRT, IMRT is generally associated
with longer treatment planning times and treatment times
because of its need for inverse planning and complex beam
delivery [19,20]. In the present study, we found that the 
median beam delivery time was the shortest for 2F-3DCRT
(2.06 minutes) and longest for TH-IMRT (2.9 minutes); 
however, the difference was less than 1 minute. The beam
delivery time of full-arc VMAT was generally less than 2
minutes, although the results may vary with the type of
equipment and the dose rate used [21]. Therefore, full-
arc VMAT offers slightly shorter beam delivery times than
the plans studied here. However, the difference is not 
particularly substantial from a clinical perspective. The treat-
ment planning time of IMRT is much longer than that of 
2F-3DCRT. Particularly, the treatment planning time of full-
arc VMAT (which usually requires inverse planning for the
full arc) is much longer than that of 3F-IMRT.
TH-3DCRT is a conformal arc technique that modifies the
beam by opening the MLC in accordance to the shape of the
TV in a helical mode (without beam intensity modulation).
The treatment planning times and treatment times of 
TH-3DCRT are short (total of less than 30 minutes) because
TH-3DCRT does not include intensity modulation and addi-
tional patient-specific pretreatment quality assurance is not
required due to the simple treatment method. At our center,
we perform dose verification of the absolute point dose using
an ionization chamber and the relative dose distributions
using Gafchromic film (EBT, ISP, Wayne, NJ) with a solid
phantom before treatment for all IMRT sessions (Table 2).
These procedures include measurements and analysis, and
take about 2 hours. When TH-3DCRT was initially intro-
duced, the exact same quality assurance procedures were
performed as part of the commissioning process. However,
TH-3DCRT has not been performed as a general 3D-CRT
procedure after the correct delivery dose was confirmed.
Therefore, the same-day treatment with a CT plan may also
be worth considering. 
Setup margin and motion are important factors for a 
successful treatment of EGC. The patient’s larynx is reported
to move 20-25 mm in the caudal-cranial direction and 3-8
mm in the anterior-posterior direction during swallowing
[13,22,23]. However, the incidence and duration of swallow-
ing are reported to be small in most patients. Hence, patients
at our center receive thorough instructions not to swallow
during treatment, and we try to shorten the treatment time
as much as possible. Several previous studies reported that,
when treating EGC with daily image-guided repositioning
using a CTV-PTV margin of 1-2 mm, there is a very small
CTV dose reduction due to geometrical uncertainty, includ-
ing set-up errors, respiratory movements, interfractional 
volumetric changes, and deformations that occur during
treatment. Nonetheless, sparing of OAR remains unchanged
[12,24,25]. The CTV-PTV margin added in this study was 3
mm in all directions, except posteriorly (1 mm). This was
considered to be a safe margin for TH-3DCRT and TH-IMRT,
which involve simultaneous megavoltage CT image-guid-
ance and the use of a thermoplastic mask.
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Conclusion
In this study, we showed that TH-3DCRT provides many
new benefits, excellent target dose coverage, and CA-sparing
similar to that of the other two IMRT techniques. TH-3DCRT
also offers high efficiency, short planning times, and short
beam delivery times (similar to 3DCRT). In addition, 
pretreatment quality assurance is not required due to the
simplicity of the treatment method. This study may serve as
an effective guide for selecting the best-performing method
of treatment for EGC that also requires the lowest workload.
A suitable balance of performance and workload can be 
especially advantageous for busy clinics.
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